135 related articles for article (PubMed ID: 25530551)
1. Prostate cancer prevalence in New South Wales Australia: a population-based study.
Yu XQ; Luo Q; Smith DP; Clements MS; O'Connell DL
Cancer Epidemiol; 2015 Feb; 39(1):29-36. PubMed ID: 25530551
[TBL] [Abstract][Full Text] [Related]
2. A population-based study of breast cancer prevalence in Australia: predicting the future health care needs of women living with breast cancer.
Yu XQ; De Angelis R; Luo Q; Kahn C; Houssami N; O'Connell DL
BMC Cancer; 2014 Dec; 14():936. PubMed ID: 25494610
[TBL] [Abstract][Full Text] [Related]
3. Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study.
Yu XQ; Luo Q; Smith DP; Clements MS; Patel MI; O'Connell DL
PLoS One; 2017; 12(2):e0171013. PubMed ID: 28178275
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of cases with unknown stage prostate cancer in a population-based cancer registry.
Luo Q; Yu XQ; Cooke-Yarborough C; Smith DP; O'Connell DL
Cancer Epidemiol; 2013 Dec; 37(6):813-9. PubMed ID: 24103424
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen testing in Australia and association with prostate cancer incidence in New South Wales.
Smith DP; Armstrong BK
Med J Aust; 1998 Jul; 169(1):17-20. PubMed ID: 9695696
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer and prostate-specific antigen testing in New South Wales.
Smith DP; Supramaniam R; Marshall VR; Armstrong BK
Med J Aust; 2008 Sep; 189(6):315-8. PubMed ID: 18803534
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer prevalence in New South Wales (Australia): Analysis of past trends and projection of future estimates.
Yu XQ; Kahn C; Luo Q; Sitas F; O'Connell DL
Cancer Epidemiol; 2015 Aug; 39(4):534-8. PubMed ID: 26070508
[TBL] [Abstract][Full Text] [Related]
8. Current and future burden of incident hip fractures in New South Wales, Australia.
Stephens AS; Toson B; Close JC
Arch Osteoporos; 2014; 9():200. PubMed ID: 25385340
[TBL] [Abstract][Full Text] [Related]
9. Estimation and projections of cancer prevalence from cancer registry data.
Verdecchia A; De Angelis G; Capocaccia R
Stat Med; 2002 Nov; 21(22):3511-26. PubMed ID: 12407687
[TBL] [Abstract][Full Text] [Related]
10. An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high?
Feletto E; Bang A; Cole-Clark D; Chalasani V; Rasiah K; Smith DP
World J Urol; 2015 Nov; 33(11):1677-87. PubMed ID: 25698456
[TBL] [Abstract][Full Text] [Related]
11. Increased risk of suicide in New South Wales men with prostate cancer: Analysis of linked population-wide data.
Smith DP; Calopedos R; Bang A; Yu XQ; Egger S; Chambers S; O'Connell DL
PLoS One; 2018; 13(6):e0198679. PubMed ID: 29897979
[TBL] [Abstract][Full Text] [Related]
12. Changes in prostate cancer incidence, mortality and survival in relation to prostate specific antigen testing in New South Wales, Australia.
Luo Q; Yu XQ; Kahn C; Egger S; Patel MI; Grogan PB; Caruana M; Canfell K; Smith DP; O'Connell DL
Cancer Epidemiol; 2022 Jun; 78():102159. PubMed ID: 35447540
[TBL] [Abstract][Full Text] [Related]
13. Second primary cancers after cancers of the colon and rectum in New South Wales, Australia, 1972-1991.
McCredie M; Macfarlane GJ; Bell J; Coates M
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):155-60. PubMed ID: 9138657
[TBL] [Abstract][Full Text] [Related]
14. Modelling and calibration of the hepatitis C epidemic in Australia.
Razali K; Amin J; Dore GJ; Law MG; HCV Projections Working Group
Stat Methods Med Res; 2009 Jun; 18(3):253-70. PubMed ID: 19036911
[TBL] [Abstract][Full Text] [Related]
15. Patterns of surgical care for prostate cancer in NSW, 1993-2002: rural/urban and socio-economic variation.
Hayen A; Smith DP; Patel MI; O'Connell DL
Aust N Z J Public Health; 2008 Oct; 32(5):417-20. PubMed ID: 18959543
[TBL] [Abstract][Full Text] [Related]
16. Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends.
Telesca D; Etzioni R; Gulati R
Biometrics; 2008 Mar; 64(1):10-9. PubMed ID: 17501937
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era.
Konety BR; Bird VY; Deorah S; Dahmoush L
J Urol; 2005 Nov; 174(5):1785-8; discussion 1788. PubMed ID: 16217287
[TBL] [Abstract][Full Text] [Related]
18. Dramatic increase in prostate cancer cases by 2021.
Quon H; Loblaw A; Nam R
BJU Int; 2011 Dec; 108(11):1734-8. PubMed ID: 21507185
[TBL] [Abstract][Full Text] [Related]
19. Recent trends in prostate cancer testing and incidence among men under age of 50.
Li J; German R; King J; Joseph D; Thompson T; Wu XC; Ajani U; Tai E
Cancer Epidemiol; 2012 Apr; 36(2):122-7. PubMed ID: 22112545
[TBL] [Abstract][Full Text] [Related]
20. Self-reported prevalence of prostate-specific antigen testing in South Australia: a community study.
Pinnock CB; Weller DP; Marshall VR
Med J Aust; 1998 Jul; 169(1):25-8. PubMed ID: 9695698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
